Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evandro de Azambuja

Showing results (91-100 of 259) with videos related to

Pageof 26
Sort By:
Critical Reviews in Oncology/Hematology|April 7, 2020
Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trialsRafael Caparica, Marco Bruzzone, Georges El Hachem, et al.
ESMO Open|August 28, 2020
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysisMariana Brandão, Christian Maurer, Patricia Klarmann Ziegelmann, et al.
Breast Cancer Research : BCR|June 21, 2012
Targeted therapies in breast cancer: are heart and vessels also being targeted?Carmen Criscitiello, Otto Metzger-Filho, Kamal S Saini, et al.
Clinical Breast Cancer|March 21, 2024
The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA TrialVeronique Debien, Elisa Agostinetto, Marco Bruzzone, et al.
Cancer Treatment Reviews|May 7, 2013
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancerKamal S Saini, Sherene Loi, Evandro de Azambuja, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2023
Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysisFlavia Jacobs, Chiara Molinelli, Diogo Martins-Branco, et al.
NPJ Breast Cancer|May 19, 2025
Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapyC Florin Pop, Clémence Ortega, Mathilde Lecomte, et al.
Breast Cancer Research and Treatment|April 5, 2020
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitorsMaria Alice Franzoi, Caroline Vandeputte, Daniel Eiger, et al.
ESMO Open|June 27, 2018
Single-agent PARP inhibitors for the treatment of patients with <i>BRCA</i>-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysisFrancesca Poggio, Marco Bruzzone, Marcello Ceppi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression DataIvana Bozovic-Spasojevic, Dimitrios Zardavas, Sylvain Brohée, et al.
Pageof 26

Showing results (91-100 of 259) with videos related to

Sort By:
Pageof 26
Critical Reviews in Oncology/Hematology|April 7, 2020
Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trialsRafael Caparica, Marco Bruzzone, Georges El Hachem, et al.
ESMO Open|August 28, 2020
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysisMariana Brandão, Christian Maurer, Patricia Klarmann Ziegelmann, et al.
Breast Cancer Research : BCR|June 21, 2012
Targeted therapies in breast cancer: are heart and vessels also being targeted?Carmen Criscitiello, Otto Metzger-Filho, Kamal S Saini, et al.
Clinical Breast Cancer|March 21, 2024
The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA TrialVeronique Debien, Elisa Agostinetto, Marco Bruzzone, et al.
Cancer Treatment Reviews|May 7, 2013
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancerKamal S Saini, Sherene Loi, Evandro de Azambuja, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2023
Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysisFlavia Jacobs, Chiara Molinelli, Diogo Martins-Branco, et al.
NPJ Breast Cancer|May 19, 2025
Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapyC Florin Pop, Clémence Ortega, Mathilde Lecomte, et al.
Breast Cancer Research and Treatment|April 5, 2020
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitorsMaria Alice Franzoi, Caroline Vandeputte, Daniel Eiger, et al.
ESMO Open|June 27, 2018
Single-agent PARP inhibitors for the treatment of patients with <i>BRCA</i>-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysisFrancesca Poggio, Marco Bruzzone, Marcello Ceppi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression DataIvana Bozovic-Spasojevic, Dimitrios Zardavas, Sylvain Brohée, et al.
Pageof 26